Table 4.
Characteristic | Pt.1 | Pt.2 | Pt.3 | Pt.4 | Pt.5 | |||||
---|---|---|---|---|---|---|---|---|---|---|
Age | 56 | 29 | 44 | 57 | 35 | |||||
Sex | F | F | M | F | F | |||||
Disease onset | HF | HF | HF | HF | VT | |||||
Family history | ||||||||||
DCM | + | + | + | + | - | |||||
SCD <45y | - | - | + | - | - | |||||
Symptoms | ||||||||||
Syncope | - | - | - | - | + | |||||
NYHA | II | III | III | II | I | |||||
ECG abnormalities | ||||||||||
Low voltage | - | - | - | + | + | |||||
Reduced R amplitude | - | + | + | + | + | |||||
Repolarization abnormalities | + | - | - | - | - | |||||
TTE | ||||||||||
LVDd/LVDs (mm) | 53/44 | 68/59 | 74/71 | 54/48 | 46/43 | |||||
IVS/PW (mm) | 9/6 | 9/7 | 10/10 | 8/8 | 8/6 | |||||
LVEF (%) | 35 | 35 | 9 | 24 | 30 |
‘Low voltage’ is defined as QRS peak-to-peak amplitude in leads I, II, and III <0.5 mV, the sum of the amplitudes <1.5 mV, and amplitude in all precordial leads <1.0 mV (3). ‘Reduced R amplitude’ is defined as R waves <3 mm for at least five of six limb leads or <5 mm for five of six precordial leads (8). ‘Repolarization abnormalities’ is defined as fulfilling the major or minor criteria as described in the modified ARVC/D task force criteria (18).
ARVC/D: arrhythmogenic right ventricular cardiomyopathy/dysplasia, DCM: dilated cardiomyopathy, ECG: electrocardiogram, IVS: interventricular septum, LVDd: left ventricular end-diastolic dimension, LVDs: end-systolic dimension, LVEF: left ventricular ejection fraction, PW: posterior wall, SCD: sudden cardiac death, TTE, transthoracic echocardiography